Provectus Biopharmaceuticals - 45 Year Dividend History | PVCT
Historical dividend payout and yield for Provectus Biopharmaceuticals (PVCT) since 1971. The current TTM dividend payout for Provectus Biopharmaceuticals (PVCT) as of October 13, 2016 is $0.00. The current dividend yield for Provectus Biopharmaceuticals as of October 13, 2016 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.050B |
$0.001B |
|
Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. The company's product portfolio consists of PV-10 Melanoma, PH-10 Psoriasis, PH-10 Atopic Dermatitis, PV-10 Breast Cancer, PV-10 Liver Metastasis and PV-10 Mechanism of Action which are in clinical trials. Provectus Biopharmaceuticals Inc., formerly known as Provectus Pharmaceuticals, Inc., is based in Knoxville, Tennessee.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
